1-[2-(4-chlorophenyl)ethyl]-1H-1,3-benzodiazol-5-amine, 95.0%, 250mg

3-(3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)phenyl)propanoic acid, 98%, 5g

1-(4,5-Dinitro-10-aza-tricyclo[6.3.1.02,7]dodeca-2(7),3,5-trien-10-yl)-2,2,2-trifluoro-ethanone, 98%, 10g

2,2'-Dipyridyl-4,4'-dicarboxylic acid, 97.0%, 5g

Ethyl 3-Furancarboxylate>98.0%(GC)25g

2-amino-N-(2,4-dimethylphenyl)benzamide, 95.0%, 5g

(11BS)-2,6-bis(3,5-di-tert-butylphenyl)-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 98%, 1g

Ethyl 4-(3,5-dimethyl-4-methoxyphenyl)-4-oxobutyrate, 97.0%, 1g

BMeS-p-A>95.0%(HPLC)1g

Reactores para síntesis de péptidos, 10 ml, 10 piezas, 10 piezas

Aparato ultrasónico Elmasonic P, 12,75 l, P 120H 1 Pieza

8-Chloro-6,7-difluoro-1-((1R,2S)-2-fluorocyclopropyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 1g

tert-Butyl 2-oxo-6-azaspiro[3.4]octane-6-carboxylate, 95.0%, 25g